Immune-mediated syndromes following intravenous bisphosphonate therapy

ConclusionsIntravenous ABP may trigger induction of persistent autoimmune syndromes, especially when accompanied by an immediate adverse reaction or pre-existing malignancy.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research